<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82">
  <stage>Registered</stage>
  <submitdate>28/07/2005</submitdate>
  <approvaldate>1/08/2005</approvaldate>
  <actrnumber>ACTRN12605000065695</actrnumber>
  <trial_identification>
    <studytitle>The effect of intrathecal pethidine on shivering in women having caesarean sections: a prospective randomised controlled trial</studytitle>
    <scientifictitle>The effect of intrathecal pethidine on shivering in women having caesarean sections: a prospective randomised controlled trial</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Shivering in women having caesarean sections under spinal anaesthetics</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Normal pregnancy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Women presenting for emergency caesarean section (E1-E3) will be randomised to one of two groups, and either receive intrathecal pethidine 10mg with bupivacaine, or intrathecal fentanyl 10mcg with bupivacaine.  Our hypothesis is that women receiving pethidine will experience less shivering than those receiveing fentanyl.  
The intervention will last four hours only.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Shivering</outcome>
      <timepoint>It will be measured on arrival to the operating theatre, at 20 minutely intervals during the operation, and once in recovery.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Height of block</outcome>
      <timepoint>Will be recorded during the operation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Presence or absence of nausea, vomiting, itch, intraoperative pain, hypotension.</outcome>
      <timepoint>Will be recorded during the operation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>VAS pain scores</outcome>
      <timepoint> at 4 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to first supplemental analgesia requirement.</outcome>
      <timepoint>Will be recorded during the operation.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women having urgent caesarean sections (E1-E3).</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Epidural catheter in situ. Spinal anaesthetic not the most appropriate anaesthetic. ASA &gt; 3- code greens.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The syringe containing the opiate will be prepared by the hospital pharmacy. The syringes for both groups will appear identical. The syringes will be numbered 0-40 by pharmacy. Pharmacy will randomly number the syringes (computer generated). The anaesthetic nurse will randomly choose a syringe from a box containing the syringes.</concealment>
    <sequence>Computer generated. No restriction.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/09/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Box Hill Hospital, Eastern Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none required</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Gabe Snyder</name>
      <address>Box Hill Hospital
Nelson Road
Box Hill VIC 3128</address>
      <phone>+61 3 9895333</phone>
      <fax />
      <email>gabrielsnyder@hotmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Gabe Snyder</name>
      <address>Box Hill Hospital
Nelson Road
Box Hill VIC 3128</address>
      <phone>+61 3 9895333</phone>
      <fax />
      <email>gabrielsnyder@hotmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>